Literature DB >> 17031836

Strengths and weaknesses of dark-lumen MR colonography: clinical relevance of polyps smaller than 5 mm in diameter at the moment of their detection.

Waleed Ajaj1, Stefan G Ruehm, Guido Gerken, Mathias Goyen.   

Abstract

PURPOSE: To assess the clinical relevance of dark-lumen MR colonography (MRC) for the detection of colorectal lesions using conventional colonoscopy (CC) and histopathologic examinations as reference standard.
MATERIALS AND METHODS: A total of 72 patients underwent MRC and CC. MRC was performed using a contrast-enhanced high spatial resolution T1 weighted 3D volumetric interpolated breathhold examination (VIBE)-sequence. All removed colorectal lesions were evaluated by an experienced pathologist.
RESULTS: CC confirmed 65 polyps less than 5 mm in diameter. Non of those lesions could be detected using MRC. Just two (4%) of the 49 removed lesions smaller than 5 mm showed signs of dysplasia. Additionally, CC confirmed 25 polyps between 6-15 mm in diameter (MRC 22). All those 25 lesions were removed in CC. Only four (16%) of those polyps showed signs of dysplasia and malignancy (11, 13, 13 and 15 mm).
CONCLUSION: Dark-lumen MRC failed to detect all polyps smaller than 5 mm in diameter which are generally not clinically relevant at the moment of their detection and thus can be kept under surveillance. However, MRC as a non-invasive imaging modality is a promising alternative to CC in the detection of clinically relevant polyps larger than 5 mm in diameter. Copyright (c) 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17031836     DOI: 10.1002/jmri.20734

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  9 in total

1.  Magnetic Resonance (MR) Colonography for Colorectal Cancer Screening: An Evidence-Based Analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-09-01

2.  Screening methods for early detection of colorectal cancers and polyps: summary of evidence-based analyses.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2009-09-01

Review 3.  Virtual gastrointestinal colonoscopy in combination with large bowel endoscopy: clinical application.

Authors:  Qing He; Ting Rao; Yong-Song Guan
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

4.  Colorectal neoplasm: magnetic resonance colonography with fat enema-initial clinical experience.

Authors:  Shuai Zhang; Jun-Wei Peng; Qiang-Ying Shi; Feng Tang; Min-Guo Zhong
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

5.  Functional colonography of Min mice using dark lumen dynamic contrast-enhanced MRI.

Authors:  C Chad Quarles; Martin Lepage; D Lee Gorden; Barbara Fingleton; Thomas E Yankeelov; Ronald R Price; Lynn M Matrisian; John C Gore; J Oliver McIntyre
Journal:  Magn Reson Med       Date:  2008-09       Impact factor: 4.668

Review 6.  Colonography by CT, MRI and PET/CT combined with conventional colonoscopy in colorectal cancer screening and staging.

Authors:  Long Sun; Hua Wu; Yong-Song Guan
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

Review 7.  Terahertz endoscopic imaging for colorectal cancer detection: Current status and future perspectives.

Authors:  Pallavi Doradla; Cecil Joseph; Robert H Giles
Journal:  World J Gastrointest Endosc       Date:  2017-08-16

Review 8.  Magnetic resonance (MR) colonography in the detection of colorectal lesions: a systematic review of prospective studies.

Authors:  Frank M Zijta; Shandra Bipat; Jaap Stoker
Journal:  Eur Radiol       Date:  2009-11-21       Impact factor: 5.315

9.  Dark-lumen MR colonography with fecal tagging: a comparison of water enema and air methods of colonic distension for detecting colonic neoplasms.

Authors:  Sonia Rodriguez Gomez; Mario Pagés Llinas; Antoni Castells Garangou; Carmen De Juan Garcia; Josep M Bordas Alsina; Jordi Rimola Gibert; Juan R Ayuso Colella; Carmen Ayuso Colella
Journal:  Eur Radiol       Date:  2008-03-05       Impact factor: 7.034

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.